Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
- 1 September 1986
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 83 (18) , 7059-7063
- https://doi.org/10.1073/pnas.83.18.7059
Abstract
Mouse monoclonal antibody L6 (IgG2a subtype) recognizes a ganglioside antigen expressed at the surface of cells from human non-small-cell lung carcinomas, breast carcinomas, and colon carcinomas. We now show that this antibody can lyse L6 antigen-positive human tumor cells in the presence of Leu-11b-positive human lymphocytes (i.e., mediate antibody-dependent cellular cytotoxicity) or human serum (mediate complement-dependent cytotoxicity) and that it can inhibit the outgrowth of an L6 antigen-positive human tumor transplanted onto nude mice.Keywords
This publication has 9 references indexed in Scilit:
- MONOCLONAL MOUSE ANTIBODIES RAISED AGAINST HUMAN-LUNG CARCINOMA1986
- IMMUNOREACTIVITY ASSAY FOR LABELED ANTIMELANOMA MONOCLONAL-ANTIBODIES1986
- Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.Proceedings of the National Academy of Sciences, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?Proceedings of the National Academy of Sciences, 1984
- Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50.The Journal of Immunology, 1983
- Detection of a human melanoma‐associated antigen, p97, in histological sections of primary human melanomasInternational Journal of Cancer, 1982
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Lymphocyte-dependent antibodies to antigen 3.1, a cell-surface antigen expressed by a subgroup of human melanomasInternational Journal of Cancer, 1981